Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Ripretinib

INVICTUS

Deciphera Pharmaceuticals · Phase 3 · Completed · Enrollment 129

NCT03353753

ArmReported safety
Ripretinib 150 mgn/r
Placebon/r

A count stays a count. This page does not turn a count into a percent.